TOKYO - Japanese drugmaker Daiichi Sankyo Co. said Friday it has started manufacturing the COVID-19 vaccine of Britain's AstraZeneca Plc in Japan, as reports emerged in some European countries of blood clots in people receiving the vaccine.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
